Notice Number: NOT-CA-08-009
Key Dates
Release Date: December 28, 2007
Issued by
National Cancer Institute (NCI) (www.cancer.gov)
This Notice is to inform applicants that the National Cancer Institute (NCI) is participating in funding opportunity announcement PAR-07-416, entitled Developmental Pharmacology (R01).
The following Institutes continue to participate in PAR-07-416:
National Institute of Child Health and Human Development (NICHD) (http://www.nichd.nih.gov)
National Institute of General Medical Sciences (NIGMS) (http://www.nigms.nih.gov)
National Institute of Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov)
National Institute on Drug Abuse (NIDA) (http://www.nichd.nih.gov)
National Institute of Environmental Health Sciences (NIEHS) (http:/www.niehs.nih.gov)
Inquiries
For scientific/research inquiries to the NCI, contact:
William C. Timmer, Ph.D.
Clinical Grants and Contracts Branch
Cancer Therapy Evaluation Program
Division of Cancer Therapy and Diagnosis
National Cancer Institute
National Institutes of Health
6130 Executive Boulevard, EPN Room 7009, MSC 7432
Bethesda, MD 20892-7432 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for non-USPS delivery)
Main Office Telephone: (301) 496-8866
Direct Telephone: (301) 594-9796
Fax: (301) 480-4663
E-mail: [email protected]
and Human Services (HHS)
